81 related articles for article (PubMed ID: 23280471)
1. Inducible expression of kallikrein in renal tubular cells protects mice against spontaneous lupus nephritis.
Shao X; Yang R; Yan M; Li Y; Du Y; Raman I; Zhang B; Wakeland EK; Igarashi P; Mohan C; Li QZ
Arthritis Rheum; 2013 Mar; 65(3):780-91. PubMed ID: 23280471
[TBL] [Abstract][Full Text] [Related]
2. Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress.
Zhang JJ; Bledsoe G; Kato K; Chao L; Chao J
Kidney Int; 2004 Aug; 66(2):722-32. PubMed ID: 15253727
[TBL] [Abstract][Full Text] [Related]
3. Kallikrein transduced mesenchymal stem cells protect against anti-GBM disease and lupus nephritis by ameliorating inflammation and oxidative stress.
Li Y; Raman I; Du Y; Yan M; Min S; Yang J; Fang X; Li W; Lu J; Zhou XJ; Mohan C; Li QZ
PLoS One; 2013; 8(7):e67790. PubMed ID: 23935844
[TBL] [Abstract][Full Text] [Related]
4. Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene delivery.
Bledsoe G; Shen B; Yao Y; Zhang JJ; Chao L; Chao J
Hum Gene Ther; 2006 May; 17(5):545-55. PubMed ID: 16716111
[TBL] [Abstract][Full Text] [Related]
5. Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans.
Liu K; Li QZ; Delgado-Vega AM; Abelson AK; Sánchez E; Kelly JA; Li L; Liu Y; Zhou J; Yan M; Ye Q; Liu S; Xie C; Zhou XJ; Chung SA; Pons-Estel B; Witte T; de Ramón E; Bae SC; Barizzone N; Sebastiani GD; Merrill JT; Gregersen PK; Gilkeson GG; Kimberly RP; Vyse TJ; Kim I; D'Alfonso S; Martin J; Harley JB; Criswell LA; ; ; ; ; ; ; Wakeland EK; Alarcón-Riquelme ME; Mohan C
J Clin Invest; 2009 Apr; 119(4):911-23. PubMed ID: 19307730
[TBL] [Abstract][Full Text] [Related]
6. Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation.
Hagiwara M; Shen B; Chao L; Chao J
Hum Gene Ther; 2008 Aug; 19(8):807-19. PubMed ID: 18554097
[TBL] [Abstract][Full Text] [Related]
7. The lupus-susceptibility gene kallikrein downmodulates antibody-mediated glomerulonephritis.
Li QZ; Zhou J; Yang R; Yan M; Ye Q; Liu K; Liu S; Shao X; Li L; Zhou XJ; Wakeland EK; Mohan C
Genes Immun; 2009 Jul; 10(5):503-8. PubMed ID: 19262577
[TBL] [Abstract][Full Text] [Related]
8. Micro-RNA analysis of renal biopsies in human lupus nephritis demonstrates up-regulated miR-422a driving reduction of kallikrein-related peptidase 4.
Krasoudaki E; Banos A; Stagakis E; Loupasakis K; Drakos E; Sinatkas V; Zampoulaki A; Papagianni A; Iliopoulos D; Boumpas DT; Bertsias GK
Nephrol Dial Transplant; 2016 Oct; 31(10):1676-86. PubMed ID: 26546590
[TBL] [Abstract][Full Text] [Related]
9. Protective role for CCR5 in murine lupus nephritis.
Turner JE; Paust HJ; Bennstein SB; Bramke P; Krebs C; Steinmetz OM; Velden J; Haag F; Stahl RA; Panzer U
Am J Physiol Renal Physiol; 2012 Jun; 302(11):F1503-15. PubMed ID: 22442210
[TBL] [Abstract][Full Text] [Related]
10. Bindarit retards renal disease and prolongs survival in murine lupus autoimmune disease.
Zoja C; Corna D; Benedetti G; Morigi M; Donadelli R; Guglielmotti A; Pinza M; Bertani T; Remuzzi G
Kidney Int; 1998 Mar; 53(3):726-34. PubMed ID: 9507220
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
12. Kallikreins and lupus nephritis.
Ponticelli C; Meroni PL
J Clin Invest; 2009 Apr; 119(4):768-71. PubMed ID: 19348047
[TBL] [Abstract][Full Text] [Related]
13. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus.
Boswell JM; Yui MA; Endres S; Burt DW; Kelley VE
J Immunol; 1988 Jul; 141(1):118-24. PubMed ID: 3259964
[TBL] [Abstract][Full Text] [Related]
14. Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain.
Xie C; Zhou XJ; Liu X; Mohan C
Arthritis Rheum; 2003 Apr; 48(4):1080-92. PubMed ID: 12687552
[TBL] [Abstract][Full Text] [Related]
15. Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis.
Boswell JM; Yui MA; Burt DW; Kelley VE
J Immunol; 1988 Nov; 141(9):3050-4. PubMed ID: 3262676
[TBL] [Abstract][Full Text] [Related]
16. Local synthesis of interferon-alpha in lupus nephritis is associated with type I interferons signature and LMP7 induction in renal tubular epithelial cells.
Castellano G; Cafiero C; Divella C; Sallustio F; Gigante M; Pontrelli P; De Palma G; Rossini M; Grandaliano G; Gesualdo L
Arthritis Res Ther; 2015 Mar; 17(1):72. PubMed ID: 25889472
[TBL] [Abstract][Full Text] [Related]
17. Cross-contamination with tamoxifen induces transgene expression in non-exposed inducible transgenic mice.
Brake RL; Simmons PJ; Begley CG
Genet Mol Res; 2004 Dec; 3(4):456-62. PubMed ID: 15688312
[TBL] [Abstract][Full Text] [Related]
18. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
[TBL] [Abstract][Full Text] [Related]
19. Kallikrein/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosis.
Bledsoe G; Crickman S; Mao J; Xia CF; Murakami H; Chao L; Chao J
Nephrol Dial Transplant; 2006 Mar; 21(3):624-33. PubMed ID: 16401625
[TBL] [Abstract][Full Text] [Related]
20. L-arginine supplementation accelerates renal fibrosis and shortens life span in experimental lupus nephritis.
Peters H; Border WA; Rückert M; Krämer S; Neumayer HH; Noble NA
Kidney Int; 2003 Apr; 63(4):1382-92. PubMed ID: 12631354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
